🔎 Trials Near Me

Home › Mga Seizure › Washington

Pag-aaral pangklinika para sa Mga Seizure sa Washington, DC

Isang pag-aaral para sa Mga Seizure ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Washington. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Investigating Epilepsy: Screening and Evaluation

Nagre-recruitObservasyonal na pag-aaral
  • National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Edad 8 hanggang 110 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT03478852

Natural History of Treated Neurocysticercosis and Long-Term Outcomes

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Edad 3 hanggang 99 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT00001205

Tumor Related Epilepsy

Nagre-recruitObservasyonal na pag-aaral
  • National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Edad 8 hanggang 99 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT02639325

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

Nagre-recruitPhase 1
  • Mid-Atlantic Epilepsy and Sleep Center, Bethesda · 7 mi ang layo
Edad 12 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07233239

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

Nagre-recruitPhase 3
  • Mid-Atlantic Epilepsy and Sleep Center, Bethesda · 7 mi ang layo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07563881

RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

Nagre-recruitPhase 2
  • Mid Atlantic Epilepsy and Sleep Center, Bethesda · 7 mi ang layo
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06798896

Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy

Nagre-recruitPhase 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT02531880

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

Nagre-recruitPhase 3
  • George Washington University, Washington D.C.
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hun 9, 2026 · NCT05135091

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

Nagre-recruitPhase 3
  • Mid-Atlantic Epilepsy and Sleep Center, Bethesda · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update May 14, 2026 · NCT05716100

Pediatric Dose Optimization for Seizures in Emergency Medical Services

Nagre-recruitPhase 3
  • Children's National Hospital, Washington D.C.
6 Months – 13 Years · Lahat ng kasarian · Na-update Set 30, 2025 · NCT05121324

Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

Nagre-recruitPhase 3
  • Mid-Atlantic Epilepsy and Sleep Center, Bethesda · 7 mi ang layo
Edad 4 hanggang 55 · Lahat ng kasarian · Na-update Hul 24, 2025 · NCT05219617

An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures

Nagre-recruitPhase 2
  • Praxis Research Site, Bethesda · 7 mi ang layo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Abr 3, 2025 · NCT06908356

Epilepsy Learning Healthcare System (ELHS)

Nagre-recruitObservasyonal na pag-aaral
  • Epilepsy Foundation, Bowie · 17 mi ang layo
Lahat ng edad · Lahat ng kasarian · Na-update Ago 30, 2024 · NCT06265103

Pag-aaral para sa Mga Seizure sa ibang lungsod

Iba pang pag-aaral sa Washington

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.